Skip to search formSkip to main contentSkip to account menu

mutacin 1140

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
The emergence of antibiotic-resistance is a major concern to global human health and identification of novel antibiotics is… 
2018
2018
Lantibiotics offer an untapped pipeline for the development of novel antibiotics to treat serious Gram-positive (+) infections… 
2018
2018
Lantibiotics represent a large untapped pipeline of attractive scaffolds for the development of novel antibiotics. Saturation… 
2018
2018
Lantibiotics continue to offer an untapped pipeline for the development of novel antibiotics. We report here the discovery of a… 
2017
2017
ABSTRACT Mutacin 1140 belongs to the epidermin group of lantibiotics. Epidermin class lantibiotics are ribosomally synthesized… 
2015
2015
ABSTRACT Lantibiotics are ribosomally synthesized peptide antibiotics composed of an N-terminal leader peptide that is cleaved to… 
2014
2014
Lantibiotics are ribosomally synthesized peptide antibiotics composed of an N‐terminal leader peptide that promotes the core… 
Highly Cited
2008
Highly Cited
2008
Mutacin 1140 and nisin A are peptide antibiotics that belong to the lantibiotic family. N-Terminal rings A and B of nisin A and… 
2003
2003
Mutacin 1140 is a member of a family of ribosomally synthesized peptide bacteriocins called lantibiotics (lanthionine-containing…